KIM-1 (in urine and plasma) has been widely recognized as an early biomarker of AKI and CKD in models of drug-induced nephrotoxicity, ischemia–reperfusion, among others [28, 29, 59–61]. The gene discussed is HAVCR1; the disease is chronic kidney disease.